Stockscreener 앱 받기
11.55
1.11%
-0.13
시간 외 거래:
11.55
Clearpoint Neuro Inc 주식(CLPT)의 최신 뉴스
What makes ClearPoint Neuro Inc. stock price move sharplyJuly 2025 Setups & Capital Protection Trade Alerts - thegnnews.com
Is ClearPoint Neuro Inc. stock entering bullish territoryJuly 2025 Outlook & Daily Entry Point Alerts - Newser
Why ClearPoint Neuro Inc. stock attracts strong analyst attention2025 Market WrapUp & Community Trade Idea Sharing - Newser
Pattern recognition hints at ClearPoint Neuro Inc. upsideEarnings Beat & Technical Buy Zone Confirmation - Newser
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates - MSN
ClearPoint Neuro outlines global expansion plans and anticipates regulatory milestones while advancing cell and gene therapy initiatives - MSN
Resistance Break Could Fuel ClearPoint Neuro Inc. RallyPortfolio Value Summary & AI Optimized Trade Strategies - sundaytimes.kr
ClearPoint Neuro: Biopharma Momentum Continues To Build - Seeking Alpha
retail investors who own 49% along with institutions invested in ClearPoint Neuro, Inc. (NASDAQ:CLPT) saw increase in their holdings value last week - simplywall.st
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q2 2025 Earnings Call Transcript - Insider Monkey
Retail investors account for 49% of ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) ownership, while institutions account for 42% - Yahoo Finance
ClearPoint Neuro Reports Record Q2 Revenue Growth - MSN
ClearPoint Neuro (CLPT): Navigating Growth Amid Margin Pressures—Is Now the Time to Enter? - AInvest
ClearPoint Neuro Inc (CLPT) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
ClearPoint Neuro Inc (CLPT) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada
ClearPoint Neuro Achieves Record Revenue in Q2 2025 - TipRanks
ClearPoint Neuro 2025 Q2 Earnings Wider Losses Amid Revenue Growth - AInvest
ClearPoint Neuro's Q2 2025: Key Contradictions in MRI Utilization, GLP Compliance, and Revenue Growth - AInvest
ClearPoint Neuro Outlines Global Expansion Plans and Advances Cell and Gene Therapy Initiatives - AInvest
Earnings call transcript: Clearpoint Neuro’s Q2 2025 earnings miss forecasts By Investing.com - Investing.com Nigeria
Earnings call transcript: Clearpoint Neuro’s Q2 2025 earnings miss forecasts - Investing.com India
ClearPoint Neuro, Inc. SEC 10-Q Report - TradingView
Clearpoint Neuro earnings missed, revenue fell short of estimates By Investing.com - Investing.com Canada
ClearPoint Neuro Q2 Loss Widens, Revenue Rises - MarketScreener
ClearPoint Neuro: Balancing Near-Term Earnings Pressure with Long-Term R&D-Driven Growth - AInvest
ClearPoint Neuro Reports Q2 2025 Record Revenue of $9.2mln, 17% YoY Increase - AInvest
ClearPoint Neuro Reports Second Quarter 2025 Results - ACCESS Newswire
ClearPoint Neuro Hits Growth Milestone with Record Q2 Revenue, Lands Major $105M Financing Deal - Stock Titan
How moving averages guide ClearPoint Neuro Inc. tradingPrice Spike Prediction for Active Traders - Newser
Is ClearPoint Neuro Inc. stock reversal real or fakeFree Day Trading Signals With High Precision - Newser
Will ClearPoint Neuro Inc. stock go up soonFree Entry Plan for Oversold Reversal Stocks - Newser
Detecting support and resistance levels for ClearPoint Neuro Inc.Trade Safety Matrix for Conservative Traders - Newser
How high can ClearPoint Neuro Inc. stock price go in 2025Free Reversal Alert Based on RSI Indicator - Newser
Chart based analysis of ClearPoint Neuro Inc. trendsFree Risk Controlled Short Term Trade Plans - Newser
Live market analysis of ClearPoint Neuro Inc.Smart Trend Analysis With Buy Point Cues - Newser
Is it too late to sell ClearPoint Neuro Inc.Support and Resistance Zone Summary Chart - Newser
Leading vs lagging indicators on ClearPoint Neuro Inc. performancePredictable Income Summary for Long-Term Trades - Newser
Is ClearPoint Neuro Inc. meeting your algorithmic filter criteriaTechnical Setup Guide for Daily Watchlist - Newser
ClearPoint Neuro (CLPT) to Release Earnings on Tuesday - Defense World
ClearPoint Neuro CLPT 2025Q2 Earnings Preview Upside Potential on Innovative Product Launch - AInvest
How ClearPoint Neuro Inc. stock performs during market volatilitySector-Wise Stock Strength Trend Analysis - Newser
Clearpoint Neuro Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $30 - 富途牛牛
Analyzing net buyer seller activity in ClearPoint Neuro Inc.Daily Market Momentum Summary and Strategy - Newser
ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio - ACCESS Newswire
Breakthrough: US Hospitals Complete First-Ever Commercial Gene Therapy Brain Treatments for Rare Disease - Stock Titan
How does ClearPoint Neuro Inc. generate profit in a changing economyHigh-profit capital plays - Jammu Links News
What catalysts could drive ClearPoint Neuro Inc. stock higher in 2025Achieve unparalleled market performance - Jammu Links News
What are analysts’ price targets for ClearPoint Neuro Inc. in the next 12 monthsFree Trend-Following Techniques - Jammu Links News
What are the technical indicators suggesting about ClearPoint Neuro Inc.Accelerated earnings growth - Jammu Links News
Should I hold or sell ClearPoint Neuro Inc. stock in 2025Invest confidently with professional market insights - Jammu Links News
Is ClearPoint Neuro Inc. stock overvalued or undervaluedExplosive wealth accumulation - Jammu Links News
How many analysts rate ClearPoint Neuro Inc. as a “Buy”Exceptional stock performance - Jammu Links News
How strong is ClearPoint Neuro Inc. company’s balance sheetBuild wealth faster with consistent growth stocks - Jammu Links News
ClearPoint Neuro Inc. Tests 50 Day MA After Sharp DeclineGrowth Based Stock Signal Screener Updated - beatles.ru
1.74%
0.24%
자본화:
|
볼륨(24시간):